A bidding war has broken into the open for the obesity-focused Metsera, with Novo Nordisk aiming to outbid Pfizer for the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

In September, the Food and Drug Administration released its recent complete response letter (CRL) to Lykos Therapeutics, ...

The Trump administration has dismantled big chunks of the federal agency focused on mental health and addiction treatment, ...

Moderna’s market value has fallen by more than 90% — $185 billion, or a full Sony — from its 2021 peak to around $10 billion ...

ACIP must endorse vaccination for all health care workers under 65. That would ensure that insurers cover the shots without ...

WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price ...

Bausch Health recently stopped participating in Medicaid and a federal government drug discount program known as 340B ...

The Trump administration has issued new guidance that threatens ongoing state efforts to keep medical debt off consumers’ ...

Multiple people have told me they’re now planning to see “Doctor Moloch,” the play about the AI doctor I brought up last week ...

BridgeBio said this morning that its investigational drug succeeded in a late-stage trial of patients with autosomal dominant ...

Texas also alleges that Johnson & Johnson fraudulently transferred liabilities arising from Tylenol to Kenvue to shield ...